294 related articles for article (PubMed ID: 36703729)
21. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
[TBL] [Abstract][Full Text] [Related]
22. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
25. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
[TBL] [Abstract][Full Text] [Related]
26. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan.
Mancia G; Korlipara K; van Rossum P; Villa G; Silvert B
Blood Press Monit; 2002 Apr; 7(2):135-42. PubMed ID: 12048432
[TBL] [Abstract][Full Text] [Related]
27. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
28. A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension.
Lee HY; Kim KI; Ihm SH; Rhee MY; Sohn IS; Park S; Jeon ES; Song JM; Pyun WB; Sung KC; Kim MH; Kim SH; Kim SY; Kim SJ; Kim EJ; Shin J; Lee SY; Chun KJ; Jeong JO; Chae SC; Yoo KD; Choi YJ; Park YH; Kim CH
Clin Ther; 2021 Oct; 43(10):1746-1756. PubMed ID: 34503866
[TBL] [Abstract][Full Text] [Related]
29. [Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial].
Fu L; Mao ZX; Wang J; Zhang J; Zheng TR; Wang SL
Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):509-13. PubMed ID: 19583930
[TBL] [Abstract][Full Text] [Related]
30. Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure.
Calzolari A; Giordano U; Matteucci MC; Pastore E; Turchetta A; Rizzoni G; Alpert B
Am J Hypertens; 1998 Apr; 11(4 Pt 1):497-501. PubMed ID: 9607390
[TBL] [Abstract][Full Text] [Related]
31. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
[TBL] [Abstract][Full Text] [Related]
33. AMBULATORY BLOOD PRESSURE VARIABILITY IN YOUNG ADULTS WITH LONG-COVID SYNDROME.
Ternushchak TM; Tovt-Korshynska MI; Varvarynets AV
Wiad Lek; 2022; 75(10):2481-2485. PubMed ID: 36472284
[TBL] [Abstract][Full Text] [Related]
34. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
35. Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trials.
Omboni S; Malacco E; Mallion JM; Volpe M
Drugs Aging; 2012 Dec; 29(12):981-92. PubMed ID: 23179896
[TBL] [Abstract][Full Text] [Related]
36. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
Mancia G; Coca A; Chazova I; Girerd X; Haller H; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
J Hypertens; 2014 Aug; 32(8):1700-7; discussion 1707. PubMed ID: 24906174
[TBL] [Abstract][Full Text] [Related]
37. Study on blood pressure rhythm in hypertensive patients withdeficiency syndrome and a random forest model for predicting hypertension withdeficiency syndrome.
Ying Z; Ping LI; Jianwei L; Rui S; Yinglan WU; Qiwen XU; Xinyue W; Yao Z; Xiangru XU; Zitian L; Yuning J; Yong Z; Yun HE; Weimin J
J Tradit Chin Med; 2024 Jun; 44(3):564-571. PubMed ID: 38767641
[TBL] [Abstract][Full Text] [Related]
38. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
[TBL] [Abstract][Full Text] [Related]
39. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
